Immunization of HLA-A1 and/or HLA-A2 positive patients
Clinical protocolHLA-A1 and/or HLA-A2 positive patients are immunized with autologous DC loaded with KLH, as immunological tracer, and an allogeneic peptidome (i.e. natural tumour peptides, NTPs), obtained from melanoma cell line SK-Mel24.
Protocol Steps:
created over 16 years ago (2 March 2009) last modified over 13 years ago (28 September 2011)  [ RDF ]  [ RelFinder ]